An overview of the effect of sodium glucose cotransporter 2 inhibitor monotherapy on glycemic and other clinical laboratory parameters in type 2 diabetes patients

OBJECTIVES: We aimed to determine the effect of sodium glucose cotransporter 2 (SGLT2) inhibitor monotherapy on glycemic and other clinical laboratory parameters versus other antidiabetic medications or placebo therapy in patients with type 2 diabetes mellitus. In addition, we aimed to investigate t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yaowen, Hu, Xueting, Liu, Xueying, Wang, Zengqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4956063/
https://www.ncbi.nlm.nih.gov/pubmed/27486328
http://dx.doi.org/10.2147/TCRM.S112236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4956063/
https://www.ncbi.nlm.nih.gov/pubmed/27486328
http://dx.doi.org/10.2147/TCRM.S112236

Ejemplares similares